Find results that contain all of your keywords. Content filter is on. Search will return best illustrations, stock vectors and clipart.
Make it so!
You have chosen to exclude "" from your results.

Choose orientation:
Explore cartoons & images using related keywords:

accessory

adaptive

antigen

blood

cancer

cascade

cell

 cells class complex cytotoxic death defense dendritic disease down helper histocompatibility human illness immune immunity immunization innate interferon killer lymphocyte major malignant medicine membrane metastasis mhc molecules natural peptide presentation presenting prevention programmed protein receptor regulation signal stimulation system therapy transduction white

The Protein PD-1 Is A Checkpoint To Slow Down T-cells. Royalty-Free Stock Photography


The protein PD-1 is a checkpoint to slow down T-cells. Stock Photo
Download
Designed by
Title
The protein PD-1 is a checkpoint to slow down T-cells. #128442095
Description

PD-1 red extends from the surface of a T-cell and interacts with the ligand protein PD-L1 yellow from a antigen presenting cell. Although the T-cell has been activated through the interaction of a T-cell receptor blue and a MHC protein violett, PD-1 regulates these activation down. It is a checkpoint to slow down T-cells.

Pembrolizumab monoclonal antibody drug protein. Immune checkpoint inhibitor targetting PD-1, used in the treatment of a number of.
Pembrolizumab monoclonal antibody drug protein. Immune checkpoint inhibitor targetting PD-1, used in the treatment of a number of.
Pembrolizumab monoclonal antibody drug protein. Immune checkpoint inhibitor targetting PD-1, used in the treatment of a number of.
Pembrolizumab monoclonal antibody drug protein. Immune checkpoint inhibitor targetting PD-1, used in the treatment of a number of.
Pembrolizumab monoclonal antibody drug protein. Immune checkpoint inhibitor targetting PD-1, used in the treatment of a number of.

Pembrolizumab monoclonal antibody drug protein. Immune checkpoint inhibitor targetting PD-1, used in the treatment of a number of.
Pembrolizumab monoclonal antibody drug protein. Immune checkpoint inhibitor targetting PD-1, used in the treatment of a number of.

Pembrolizumab monoclonal antibody drug protein. Immune checkpoint inhibitor targetting PD-1, used in the treatment of a number of.
Pembrolizumab monoclonal antibody drug protein. Immune checkpoint inhibitor targetting PD-1, used in the treatment of a number of.

Pembrolizumab monoclonal antibody drug protein. Immune checkpoint inhibitor targetting PD-1, used in the treatment of a number of.
Pembrolizumab monoclonal antibody drug protein. Immune checkpoint inhibitor targetting PD-1, used in the treatment of a number of.
Pembrolizumab monoclonal antibody drug protein. Immune checkpoint inhibitor targetting PD-1, used in the treatment of a number of.
Pembrolizumab monoclonal antibody drug protein. Immune checkpoint inhibitor targetting PD-1, used in the treatment of a number of.
Pembrolizumab monoclonal antibody drug protein. Immune checkpoint inhibitor targetting PD-1, used in the treatment of a number of